Impact of interleukin 28B rs12979860 C/T polymorphism on severity of disease and response to treatment in hepatitis delta

Introduction: Pegylated-interferon alpha (Peg-IFN α) is the therapy most commonly used to treat chronic hepatitis delta virus (HDV) infection. In the present study, we planned to investigate effect of IL28B polymorphism on response to Peg-IFN α therapy and disease progression in patients with chroni...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Murat Ispiroglu, Ibrahim Halil Bahcecioglu, Ulvi Demirel, Mehmet Yalniz
Format: Artigo
Idioma:Inglês
Publicat: The Journal of Infection in Developing Countries 2017-01-01
Col·lecció:Journal of Infection in Developing Countries
Matèries:
Delta hepatitis
interleukin 28B
interferon
Accés en línia:https://jidc.org/index.php/journal/article/view/6872
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars